Personal Information
Entreprise/Lieu de travail
Korea, Seoul Korea, South
Profession
Founder & CEO at Bridge Biotherapeutics, Inc
Secteur d’activité
Medical / Health Care / Pharmaceuticals
À propos
I am serial biotech entrepreneur, finding assets locally to develop them globally.
Firstly I co-founded CrystalGenomics after 7 and half years at LG Life Sciences as researcher BD manager. CrystalGenomics, backed by local VCs, went public in 2006 successfully and got an approval of Acelex® (polmacoxib) in Korea. Secondly, Rexbio was founded for the development of mAb against PAUF, which is specifically over-expressed at pancreatic adenocarcinoma.
Specialties: Technology assessment
Formulation of R&D/Business strategy
Mots-clés
bridge biotherapeutics
biotechnology
korean biopharma industry r&d
global perspective
미래에셋대우증권
ir
함께의 미학
한국 제약바이오 생태계
나의 영웅
mk 바이오헬스
창업 페스티벌
korea biotech
kasbp
entrepreneurship
hanmi open innovation forum
open innovation
스타트업
바이오텍
startup
육성방안
브릿지바이오
bridge biotherapuetics
바이오 벤처캐피탈 eir
항암제
바이오마커
ngs
최근연구개발동향
antibody scaffold
antibody scaffold mimetics
introduction
business development
Tout plus
Présentations
(16)Personal Information
Entreprise/Lieu de travail
Korea, Seoul Korea, South
Profession
Founder & CEO at Bridge Biotherapeutics, Inc
Secteur d’activité
Medical / Health Care / Pharmaceuticals
À propos
I am serial biotech entrepreneur, finding assets locally to develop them globally.
Firstly I co-founded CrystalGenomics after 7 and half years at LG Life Sciences as researcher BD manager. CrystalGenomics, backed by local VCs, went public in 2006 successfully and got an approval of Acelex® (polmacoxib) in Korea. Secondly, Rexbio was founded for the development of mAb against PAUF, which is specifically over-expressed at pancreatic adenocarcinoma.
Specialties: Technology assessment
Formulation of R&D/Business strategy
Mots-clés
bridge biotherapeutics
biotechnology
korean biopharma industry r&d
global perspective
미래에셋대우증권
ir
함께의 미학
한국 제약바이오 생태계
나의 영웅
mk 바이오헬스
창업 페스티벌
korea biotech
kasbp
entrepreneurship
hanmi open innovation forum
open innovation
스타트업
바이오텍
startup
육성방안
브릿지바이오
bridge biotherapuetics
바이오 벤처캐피탈 eir
항암제
바이오마커
ngs
최근연구개발동향
antibody scaffold
antibody scaffold mimetics
introduction
business development
Tout plus